<DOC>
	<DOCNO>NCT02180165</DOCNO>
	<brief_summary>The primary objective study ass compare safety posaconazole voriconazole Japanese participant Aspergillosis .</brief_summary>
	<brief_title>Assessing Safety Efficacy MK-5592 ( Posaconazole ) Japanese Participants With Fungal Infection ( MK-5592-101 )</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Body weight &gt; =45 kg Can treat take tablet orally intravenous ( IV ) formulation via central vein Female negative pregnancy test Female nonchildbearing potential ; childbearing potential , agree use proper combination barrier method birth control Met screen criterion either Invasive Aspergillosis , Chronic pulmonary aspergillosis , Zygomycosis Fusariosis . Has fungal infection Aspergillus specie ( spp . ) Zygomycetes ( include Mucor spp . ) Fusarium spp . infection Has allergic bronchopulmonary aspergillosis , allergic sinusitis aspergillosis , aspergillosis eye Has longterm inactive aspergilloma expect respond investigational product Is expect survive study duration Has underlying disease , complication systemic condition make difficult evaluate effect study drug Has receive , continue receive systemic antifungal therapy , discontinue treatment ; fungal infection improve , switch study drug Is expect need prohibit medication Has receive posaconazole , receive voriconazole infection past deepseated fungal infection respond treatment , intolerance azole antifungal treatment , receive antifungal combination therapy chronic pulmonary aspergillosis Has know hypersensitivity medication Has history either Torsade de Pointes , myocardial infarction within previous 90 day , congenital acquire long QT interval syndrome , unstable cardiac arrhythmia Has significant liver dysfunction Has liver cirrhosis cholestasis Has renal insufficiency Has know hereditary problem either galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption Has acute symptomatic pancreatitis within 6 month study entry chronic pancreatitis Has active skin lesion consistent squamous cell carcinoma melanoma , within prior 5 year history malignant melanoma Has know suspect Gilbert 's disease Female pregnant , nursing , intend become pregnant within 14 day end study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>